To study the effect of high-frequency Repetitive transcranial magnetic stimulation (rTMS) in cognitive function and predominantly negative symptoms in person suffering from schizophrenia in a randomized sham controlled double blind trial.
Phase 3
Completed
- Conditions
- Health Condition 1: null- Schizophrenia with negative symptoms of PANSS equal or more than 15
- Registration Number
- CTRI/2019/05/019099
- Lead Sponsor
- DEPARTMENT OF SCIENCE AND TECHNOLOGY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Schizophrenia having PANSS negative symptoms with score of 15 or more.
Willing to participate in the study
Should be able to meet ICD10 criteria
Exclusion Criteria
1.Individuals diagnosed by the investigator with the following conditions (current unless otherwise stated): Comorbid ICD-10 Axis I diagnosis, particularly current affective disorder including Depressive Disorder, Bipolar Affective Disorder; substance abuse or dependence within the past year (except nicotine and caffeine)as assessed on M.I.N.I.
History of seizure, TIA, dementia, pregnancy, any movement disorder, metallic implant within or near the head, history of rTMS intervention, implanted medicated pumps,any cardiac illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method